PEAK6 Investments’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-25,055
Closed -$612K 5206
2021
Q4
$692K Buy
+25,055
New +$671K ﹤0.01% 2912
2021
Q3
Sell
-77,133
Closed -$2.19M 5166
2021
Q2
$2.26M Sell
77,133
-73,909
-49% -$2.24M 0.01% 1775
2021
Q1
$4.79M Sell
151,042
-65,892
-30% -$1.93M 0.01% 1111
2020
Q4
$4.51M Buy
216,934
+48,556
+29% +$906K 0.01% 1140
2020
Q3
$2.62M Sell
168,378
-50,589
-23% -$871K 0.01% 1424
2020
Q2
$4M Sell
218,967
-18,594
-8% -$328K 0.01% 957
2020
Q1
$3.68M Buy
+237,561
New +$5.73M 0.02% 664
2019
Q4
Sell
-167,032
Closed -$4.34M 3398
2019
Q3
$3.65M Buy
+167,032
New +$3.82M 0.02% 887
2019
Q1
Sell
-126,928
Closed -$3.03M 3821
2018
Q4
$2.34M Buy
+126,928
New +$3.02M 0.01% 1128

Other funds holding BHC

PEAK6 Investments's BHC Position: Q1 2022 in Review

PEAK6 Investments sold out of Bausch Health (BHC) in Q1 2022, closing a stake of 25,055 shares — an estimated $612K sold.

PEAK6 Investments first reported a position in BHC in Q4 2018 and held it in 9 quarters. The position peaked at $4.79M in Q1 2021. 370 funds tracked by Wall St. Rank hold BHC as of Q1 2022.

  • PEAK6 Investments reported no remaining Bausch Health position as of Q1 2022 after selling out during the quarter.
  • PEAK6 Investments sold 25,055 Bausch Health shares in Q1 2022, an estimated $612K.
  • PEAK6 Investments first reported a position in Bausch Health in Q4 2018 and held it in 9 quarters.
  • PEAK6 Investments's Bausch Health position peaked at $4.79M in Q1 2021.
  • 370 funds tracked by Wall St. Rank held Bausch Health as of Q1 2022.

Based on PEAK6 Investments's 13F filing for Q1 2022, filed 13 May 2022.